Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | FASN | P49327 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL991915 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL3190428 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL12544948 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL23291843 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL6657704 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL25178112 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL3673738 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL23925564 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL7215629 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL10539267 | 1.00 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392621-B1 | SOLID PHASE EXTRACTION METHOD FOR OBTAINING HIGH-PURITY UNSATURATED COMPOUNDS OR DERIVATIVES OF SAID COMPOUNDS | NUTRINOVA GMBH (DE) | 2010-10-13 | — | — | EP | claimed |
| US-20230026406-A1 | THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-01-26 | — | — | US | disclosed |
| CN-113423375-A | Hair modification system | 2B1K进口私人有限公司 | 2021-09-21 | — | — | CN | disclosed |
| US-20190284152-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-09-19 | — | — | US | disclosed |
| US-10294210-B2 | Maleinated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180111912-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| US-9932542-B2 | Olefin compositions and their use as cleaning agents | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| US-9896424-B2 | Methods of making sulfurized derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-9887433-B2 | Copolymer electrolytes for secondary battery, method for preparing the same and use thereof | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2018-02-06 | — | — | US | disclosed |
| US-9738618-B2 | Malienated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2017-08-22 | — | — | US | disclosed |
| WO-2012129482-A2 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012129477-A1 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20120245063-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | WILMAR TRADING PTE LTD (SG) | 2012-09-27 | — | — | US | disclosed |
| WO-2012129479-A2 | MALIENATED DERIVATIVES | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012129490-A2 | FUNCTIONALIZED POLYMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| EP-2129746-A1 | A PROCESS FOR THE PRODUCTION OF ALIPHATIC AND CYCLIC HYDROCARBONS | Cher Ressort A.S. (CZ) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008122250-A1 | A PROCESS FOR THE PRODUCTION OF ALIPHATIC AND CYCLIC HYDROCARBONS | CHER RESSORT A.S. (CZ) | 2008-10-16 | — | — | WO | disclosed |
| EP-0662946-A1 | UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS | UNICHEMA CHEMIE B.V. (NL) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994007837-A1 | UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS | UNICHEMA CHEMIE B.V. (NL) | 1994-04-14 | — | — | WO | disclosed |
| US-4073778-A | Crown ether activated lactam polymerization | CHEVRON RESEARCH COMPANY (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111912-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | TSHR 4723/4885ALDH1A1 383/4885FASN 1691/4885 |
| US-20120245063-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | PUF60, FGB, MSN | TSHR 4545/4885ALDH1A1 562/4885FASN 17/4885 |
| US-20190284152-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | TSHR 4723/4885ALDH1A1 383/4885FASN 1691/4885 |
| US-10294210-B2 | Maleinated derivatives | SMOX, SRM, PADI2 | TSHR 4719/4885ALDH1A1 385/4885FASN 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.